LivsMed, a leader in minimally invasive surgical devices, has announced the release of ArtiSential 5, the first 5mm wristed articulating laparoscopic instrument series on the market. ArtiSential 5 represents a dramatic expansion of the company’s acclaimed ArtiSential™ line, offering enhanced flexibility and ease of use.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241001731625/en/
(Photo: Business Wire)
Introduced in 2019, the original ArtiSential is a line of single-use laparoscopic instruments with double-jointed end effectors controlled by an ergonomic grip. The end effectors move in perfect synchronization with the surgeon’s natural wrist and hand movements, offering the precision of robotic surgical platforms without the high cost. Additionally, ArtiSential provides tactile feedback, allowing surgeons to apply the right pressure to delicate tissue—something robotic systems cannot achieve. The new ArtiSential 5, which is 40% smaller than the existing 8mm line, offers significant advantages for both surgeons and patients.
ArtiSential 5 instruments are lighter and exceptionally well-balanced, making them easier to handle. Additionally, these instruments offer greater flexibility, as they can be used in any port during laparoscopic or robotic procedures. When utilized in the assist port during robotic surgery, ArtiSential 5 instruments have the potential to reduce procedure costs.
The smaller size of ArtiSential 5 can also improve visibility at the surgical site depending on the type of surgery and the angle of approach.
For patients, the use of a smaller trocar to accommodate the 5mm instrument means a smaller incision, which can result in reduced pain, faster healing, and minimal scarring.
According to LivsMed, with ArtiSential and now ArtiSential 5, the company brings wristed articulation to “any O.R., anytime… with or without the robot.” For further information email at infoUSA@livsmed.com or visit www.livsmed.us
About LivsMed
LivsMed Inc. is a medical device company that brings groundbreaking technology to minimally invasive surgery. Founded in South Korea, LivsMed is the creation of Dr. Jung Joo Lee, who envisioned a new paradigm of laparoscopic surgery where articulating technology is available to every surgeon. The ArtiSential™ line was introduced to the Korean market in 2018 and the US in 2019. Upon entering the US market, ArtiSential™ was immediately met with excitement from surgeons, receiving the Red Dot Design Award and recognition from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Working with physicians worldwide, LivsMed focuses on revolutionizing minimally invasive surgery, advancing patient outcomes and extending life for patients.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241001731625/en/
LivsMed's ArtiSential and ArtiSential 5 - Any O.R., Anytime... With or Without the Robot #ArtiSential #RoboticSurgery #LivsMed
Contacts
Media: Dave Rector daver@mrcmedical.net
